| NCT ID | NCT06748365 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sohag University |
| Condition | Diabetic Ketoacidosis |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-01-01 |
| Primary Completion | 2026-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2025-01-01 with a primary completion date of 2026-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
the aim of this study is to: evaluate the association between serum ferritin levels and the clinical presentation and short-term prognosis of patients with DKA. Specifically, the correlation between its level and the severity of DKA at presentation and determine its prognostic value in predicting short-term outcomes.
Eligibility Criteria
Inclusion Criteria: \- All patients with DKA : 1. Adult Aged 18 years old or older . 2. Type 1 DM , type 2 DM 3. Diagnosis of DKA based on the American Diabetes Association criteria: blood glucose \>250 mg/dL, arterial pH \<7.3, serum bicarbonate \<18 mEq/L, Exclusion Criteria: 1. Patients age less than 18 years old 2. Iron deficiency anemia and iron overload 3. Chronic Inflammatory Diseases: Conditions such as rheumatoid arthritis, systemic lupus erythematosus, and inflammatory bowel disease 4. Acute and chronic infections, including bacterial, viral, and fungal infections 5. Pt presented with other acute complication (MI,stroke) 6. CKD patients 7. Patients with chronic liver diseases 8. Patients with malignancy 9. Pregnant women.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06748365 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Diabetic Ketoacidosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06748365 currently recruiting?
Yes, NCT06748365 is actively recruiting participants. Contact the research team at joeisgreatyeah@gmail.com for enrollment information.
Where is the NCT06748365 trial being conducted?
This trial is being conducted at Sohag, Egypt.
Who is sponsoring the NCT06748365 clinical trial?
NCT06748365 is sponsored by Sohag University. The trial plans to enroll 100 participants.